“This is what happens when you launch a tablet the same month as Apple, at the same price,” Lam reports. “And 15 of those turned into cancellations (which were hard to do, we hear.)”
Lam reports, “That doesn’t seem like it’s enough money to cover legal fees or kick production into high gear. I’m going to reiterate our stance: It seems like a great device, but you should wait for things to shake out before putting down more money.”
Full article, with the court docs, here.
MacDailyNews Take: New record: iPad has blood on its touchscreen before it even hits customers’ hands.
[Thanks to MacDailyNews Reader "David K." for the heads up.]
5 Day Most Commented